Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 120-131
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.120
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.120
Table 2 Vaccination history in children at liver transplant and up to 5 years follow-up (n = 48)
Vaccines | Incomplete vaccination for age at transplantation | Incomplete vaccination for age after liver transplant, n (%) | |
Thai EPI program, n (%) | Accelerated vaccine from IDSA, n (%) | ||
DTP-OPV/IPV | 12 (25) | N/A | 6 (12.5) |
HBV | 6 (12.5) | 0 | |
MMR | 12 (25) | 30 (62.5)b | 27 (56.3)b |
JE | 16 (33.3) | N/A | 10 (20.8) |
Varicella | 16 (33.3) | 34 (70.8)b | 34 (70.8)b |
HAV | 26 (54) | 23 (47.9) | |
Influenza | 30 (62.5) | 18 (37.5)a | |
PCV | 36 (75) | 22 (45.8)b | |
Rota | 37 (77) | N/A | 37 (77) |
All | 25 (52) | 43 (89.5)b | 23 (47.9) |
(not included rota vaccine) | (not included lived vaccine) |
- Citation: Sintusek P, Poovorawan Y. Immunization status and hospitalization for vaccine-preventable and non-vaccine-preventable infections in liver-transplanted children. World J Hepatol 2021; 13(1): 120-131
- URL: https://www.wjgnet.com/1948-5182/full/v13/i1/120.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i1.120